Thin film drug delivery system for the transmucosal administration of a 1,4-benzoquinone derivative
EP2606022A2
Novel benzoquinone derivatives and use thereof as modulators of mitochondrial function
EP2605769A2
Benzoquinone derivatives for the treatment of mitchondrial eye diseases
EP2502917A1
Solid state crystalline forms of 4-(2-ethyl-5-fluoro-2,3-dihydro-1H-inden-2-yl)-1H-imidazole
EP2439197A1
Substituted benzimidazole derivatives as melanocortin 4 receptor antagonists
ZA200906393B
Substituted imidazopyridine derivatives as melanocortin-4 receptor antagonists
EP2246048A1
Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of primary progressive multiple sclerosis
EP2210885A1
Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators
EP2168965A1
Substituted imidazopyridine, imidazopyrazine, imidazopyridazine and imidazopyrimidine derivatives as melanocortin-4 receptor antagonists
WO2009003681A1
Dpp-iv inhibitors
EP2108366A1
Idebenone for the treatment of respiratory illness in muscular dystrophy
EP2103614A1
Substituted imidazopyrimidine, imidazopyrazine and imidazopyridazine derivatives as melanocortin-4 receptor modulators
EP2072050A1
Compounds with anti-emetic effect
EP2072516A1
Substituted imidazopyridine derivates as Melancortin-4 receptor antagonists
WO2008028662A1
N-[1-(3-amino-4-phenyl-butyryl)-4-hydroxy-pyrrolidin-2-ylmethyl}-propionamide and related compounds as dpp-iv inhibitors for the treatment of type 2 diabetes mellitus
WO2008019825A1
Use of tricyclic indole derivatives for the treatment of muscular diseases
EP2020405A1
Substituted aryl or heteroarylpiperidine derivatives as melanocortin-4 receptor modulators
EP2019100A1
Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators
EP2019099A1
Dpp-IV inhibitors
EP1974729A1
Substituted imidazopyridine derivates as melanocortin- 4 receptor antagonists
